Abstract: A method and system provide for project a safe area during an emergency situation is provided. A server, using at least one electronic sensor, determines that an emergency situation is occurring in a building. The emergency situation can be an armed intruder, a natural disaster, a chemical spill or the like, etc. The server determines likely unsafe areas and at least one likely safe area within the building during the emergency situation. A projector, which can be incorporated into a camera or separate from a camera, projects visual guidance features within the building, the visual guidance features directing occupants in the building toward the likely safe area.

Abstract: The amino acid sequence of the present IL-15 analog includes the amino acid sequence of IL-15 and an amino acid sequence including at least one positively charged amino acid added to the C-terminal of the amino acid sequence of IL-15. The present IL-15 analog is highly expressed in Escherichia Coli, wherein the expression level is about 20-fold higher than that of the wild-type IL-15, and there is no significant difference in cell activity in vitro. In addition, a conjugate of the IL-15 analog improves the half-life and the long-term efficacy of the IL-15 analog by coupling with the fatty acid chain. These improvements lay a foundation for the industrialization of IL-15 protein drugs.

Abstract: A method and system provide for project a safe area during an emergency situation is provided. A server, using at least one electronic sensor, determines that an emergency situation is occurring in a building. The emergency situation can be an armed intruder, a natural disaster, a chemical spill or the like, etc. The server determines likely unsafe areas and at least one likely safe area within the building during the emergency situation. A projector, which can be incorporated into a camera or separate from a camera, projects visual guidance features within the building, the visual guidance features directing occupants in the building toward the likely safe area.

Abstract: A method for docking an unmanned aerial vehicle (“UAV”) equipped with a wireless communications system. The method includes coupling the UAV to a docking device that is configured to provide power and data communication to the UAV via a physical interface. The method further includes receiving, at a docking device controller, an identity of the UAV, and determining, based on the received identity of the UAV, an organization associated with the UAV. The method also includes accessing, via the docking device controller, a collaborative operating profile associated with the determined organization and the identity of the UAV. The method further includes providing access to one or more resources associated with the docking station based on the collaborative operating profile.

Abstract: A method for docking an unmanned aerial vehicle (“UAV”) equipped with a wireless communications system. The method includes coupling the UAV to a docking device that is configured to provide power and data communication to the UAV via a physical interface. The method further includes receiving, at a docking device controller, an identity of the UAV, and determining, based on the received identity of the UAV, an organization associated with the UAV. The method also includes accessing, via the docking device controller, a collaborative operating profile associated with the determined organization and the identity of the UAV. The method further includes providing access to one or more resources associated with the docking station based on the collaborative operating profile.

Abstract: Compositions and methods that act on Neuropeptide S receptors (NPSR) (also known as “TGR23” or “vasopressin receptor-related receptor 1 (VRR1)”) to cause desired effects in the bodies of human or animal subjects. Neuropeptide S (NPS) and other agonists of the NPSR may be administered to cause arousal, awakening, alertness, spontaneous movement, bronchoconstriction, contraction of bronchial smooth muscle or other effects. Antagonists of the NPSR may be administered to cause decreased arousal, decreased awakening, decreased alertness, decreased spontaneous movement, sleep, somnolence, sedation, anxiolytic effects, normalized sleep patterns, normalized sleep stages, increased duration of sleep, bronchodilation, relaxation of broncheal smooth muscle or other effects.

Abstract: Compositions and methods that act on Neuropeptide S reseptors (NPSR) (also known as or “TGR23” or “vasopressin receptor-related receptor 1 (VRR1)”) to cause desired effects in the bodies of human or animal subjects. Neuropeptide S (NPS) and other agonists of the NPSR may be administered to cause arousal, awakening, alertness, spontaneous movement, bronchoconstriction, contraction of bronchial smooth muscle or other effects. Antagonists of the NPSR may be administered to cause decreased arousal, decreased awakening, decreased alertness, decreased spontaneous movement, sleep, somnolence, sedation, anxiolytic effects, normalized sleep patterns, normalized sleep stages, increased duration of sleep, bronchodilation, relaxation of broncheal smooth muscle or other effects.